Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.330 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,586
Open 1.330
Bid (Size) 1.340 (100)
Ask (Size) 1.390 (300)
Prev. Close 1.330
Today's Range 1.330 - 1.330
52wk Range 0.8000 - 4.849
Shares Outstanding 66,113,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment... 
From Neuronetics
Via GlobeNewswire

Performance

YTD
-7.6%
-7.6%
1 Month
+3.9%
+3.9%
3 Month
-2.2%
-2.2%
6 Month
-24.4%
-24.4%
1 Year
-63.6%
-63.6%

More News

Read More
News headline image
Neuronetics (STIM) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Neuronetics Inc (NASDAQ:STIM) Posts Narrower Loss in Q1 2026, Pre-Market Rises Despite Revenue Miss ↗
Via Chartmill
NEURONETICS INC (NASDAQ:STIM) Reports Q4 Revenue Beat but Shares Drop on Cautious Outlook ↗
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
Via Benzinga
News headline image
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics (STIM) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗
Via Benzinga
News headline image
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
From Neuronetics
Via GlobeNewswire
News headline image
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss ↗
Via Chartmill
News headline image
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
From Neuronetics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss ↗
Via Chartmill
News headline image
NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
From Neuronetics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Neuronetics, Inc. - Common Stock publicly traded?
Yes, Neuronetics, Inc. - Common Stock is publicly traded.
What exchange does Neuronetics, Inc. - Common Stock trade on?
Neuronetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neuronetics, Inc. - Common Stock?
The ticker symbol for Neuronetics, Inc. - Common Stock is STIM on the Nasdaq Stock Market
What is the current price of Neuronetics, Inc. - Common Stock?
The current price of Neuronetics, Inc. - Common Stock is 1.330
When was Neuronetics, Inc. - Common Stock last traded?
The last trade of Neuronetics, Inc. - Common Stock was at 06/12/26 04:00 PM ET
What is the market capitalization of Neuronetics, Inc. - Common Stock?
The market capitalization of Neuronetics, Inc. - Common Stock is 87.93M
How many shares of Neuronetics, Inc. - Common Stock are outstanding?
Neuronetics, Inc. - Common Stock has 88M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.